<DOC>
	<DOC>NCT00334503</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.</brief_summary>
	<brief_title>Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Miglitol</mesh_term>
	<criteria>Type 2 diabetic patients with Biguanide treatment Criteria for postprandial plasma glucose and HbA1c are met Type 1 diabetes Patients treated with other antidiabetic drugs or Insulin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>alpa-glucosidase inhibitor,Biguanide</keyword>
</DOC>